Cohort (n=100)
No
A newly established TAVR program in a US public hospital system demonstrated excellent clinical outcomes (1-year mortality 5%) in a highly diverse and underserved population.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Huded et al. (2026) conducted a cohort in Severe aortic stenosis (n=100). Transcatheter aortic valve replacement (TAVR) was evaluated on 1-year mortality.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: